Cargando…
Targeting STAT3 in Cancer Immunotherapy
As a point of convergence for numerous oncogenic signaling pathways, signal transducer and activator of transcription 3 (STAT3) is central in regulating the anti-tumor immune response. STAT3 is broadly hyperactivated both in cancer and non-cancerous cells within the tumor ecosystem and plays importa...
Autores principales: | Zou, Sailan, Tong, Qiyu, Liu, Bowen, Huang, Wei, Tian, Yan, Fu, Xianghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513516/ https://www.ncbi.nlm.nih.gov/pubmed/32972405 http://dx.doi.org/10.1186/s12943-020-01258-7 |
Ejemplares similares
Ejemplares similares
-
Targeting RNA G-quadruplex with repurposed drugs blocks SARS-CoV-2 entry
por: Tong, Qiyu, et al.
Publicado: (2023) -
Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy
por: Verdeil, Grégory, et al.
Publicado: (2019) -
Interleukin‐6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy
por: Kitamura, Hidemitsu, et al.
Publicado: (2017) -
Direct Targeting Options for STAT3 and STAT5 in Cancer
por: Orlova, Anna, et al.
Publicado: (2019) -
Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma
por: Dai, Xiaomeng, et al.
Publicado: (2021)